Leading the Way in Life Science Technologies

GEN Exclusives

More »
Insight & Intelligence™

Related to FDA Panel Says Nay to Full Approval of Avastin in Her2-Negative Breast Cancer

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »